Company: IXHL
Filing Date: 2025-09-29
Form Type: 10-K
Source: 0001213900-25-092837
Chunk: 112

Company: Incannex Healthcare Inc.
Filing Date: 2025-09-29
Form: 10-K
Item: Item 1
Chunk 112
---
HS laws and regulations are complex, change frequently and have tended to become more stringent over
time. Although the costs to comply with applicable laws and regulations, have not been material to date, we cannot predict the impact
on our business of new or amended laws or regulations or any changes in the way existing and future laws and regulations are interpreted
or enforced, nor can we ensure we will be able to obtain or maintain any required licenses or permits.

United States Foreign Corrupt Practices
Act

In general, the Foreign
Corrupt Practices Act of 1977, as amended (“FCPA”), prohibits offering to pay, paying, promising to pay, or authorizing the
payment of money or anything of value to a foreign official in order to influence any act or decision of the foreign official in his
or her official capacity or to secure any other improper advantage in order to obtain or retain business for or with, or in order to
direct business to, any person. The prohibitions apply not only to payments made to “any foreign official,” but also those
made to “any foreign political party or official thereof,” to “any candidate for foreign political office” or
to any person, while knowing that all or a portion of the payment will be offered, given, or promised to anyone in any of the foregoing
categories. “Foreign officials” under the FCPA include officers or employees of a department, agency, or instrumentality
of a foreign government. The term “instrumentality” is broad and can include state-owned or state-controlled entities. Importantly,
United States authorities deem most healthcare professionals and other employees of foreign hospitals, clinics, research facilities and
medical schools in countries with public healthcare and/or public education systems to be “foreign officials” under the FCPA.
When we interact with foreign healthcare professionals and researchers in testing and marketing our products abroad, should any of our
product candidates receive foreign regulatory approval in the future, we must have policies and procedures in place sufficient to prevent
us and agents acting on our behalf from providing any bribe, gift or gratuity, including excessive or lavish meals, travel or entertainment
in connection with marketing our products and services or securing required permits and approvals. The FCPA also obligates companies
whose securities are listed in the United States to comply with accounting provisions requiring us to maintain books and records that
accurately and fairly reflect all transactions of the corporation, including international subsidiaries, and to devise and maintain an
adequate system of internal accounting controls for international operations